From CNBC: 2025-02-12 06:35:45

CVS Health reported Q4 revenue and profit that beat estimates, with a full-year 2025 adjusted earnings outlook of $5.75 to $6 per share. The company saw a 4.2% revenue increase to $97.19 billion, but net income dropped to $1.64 billion. CVS struggled with rising costs in its insurance unit and lower reimbursements in retail pharmacy. Shares rose over 6% in premarket trading.

CVS’ insurance business revenue grew to $32.96 billion, up 23%, but reported an adjusted operating loss of $439 million due to higher medical costs. The medical benefit ratio increased to 94.8%, impacting profitability. The health services segment revenue dropped over 4% to $47.02 billion, processing 499.4 million pharmacy claims. The pharmacy and consumer wellness division saw sales increase to $33.51 billion, driven by higher prescription volume.



Read more at CNBC:: CVS Health (CVS) earnings Q4 2024